Phothera 200, Phototherapy Devices indicated for use to treat diagnosed skin disorders such as, but not limited to, Psoriasis, Vitiligo, and Atopic Dermatitis (Eczema) under the direction of a physici Recall

Ongoing
Medical Devices
Class II — Moderate

Recall Date

Jun 10, 2026

Company

Daavlin Distributing Company

Source

FDA

Units

368 units

Reason: Some of the Calibration/Output Certificates had the outputs reversed.

Class II: Use of the product may cause temporary or medically reversible health problems.

Official FDA recall notice

Information is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.

Recall Details

Description

Some of the Calibration/Output Certificates had the outputs reversed.

Reason for Recall

Some of the Calibration/Output Certificates had the outputs reversed.

Product: Phothera 200, Phototherapy Devices indicated for use to treat diagnosed skin disorders such as, but not limited to, Psoriasis, Vitiligo, and Atopic Dermatitis (Eczema) under the direction of a physici
Official Recall ID: FDA-DEV-Z-2295-2026
Units affected: 368 units

What Should I Do?

Check the model/lot number and contact your healthcare provider or the manufacturer.

Quantity: 368 units

Remediation GuideAction Required

5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.

1
Confirm Your Product Is Affected
2
Read the Full Recall Notice
3
Stop Using the Product if in Doubt

+2 more steps…

View Official Recall Notice (FDA)

Last updated June 16, 2026

Injured by a recalled product?

Our legal partners offer free consultations for recall victims.

Get Free Legal Help →Sponsored

Stay Informed

Weekly recall digest — free, no spam.